Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
===================================================================================================================================================================================

* Emily Maria Ploeg
* Douwe Freerk Samplonius
* Xiao Xiong
* Xiurong Ke
* Mark Alexander Johannes Martinus Hendriks
* Isabel Britsch
* Anne Paulien van Wijngaarden
* Hao Zhang
* Wijnand Helfrich